Pharmaceutical Executive-04-01-2015

Pharmaceutical Executive

Biosimilars Ramp-Up: Five Themes for the Future

April 08, 2015

Features

34

4

Although the strategic hurdles of biosimilars market entry are not new, the task of imitating substantially more complex molecular entities offers up a host of new operational questions for pharma.

Country Report: Mexico

April 01, 2015

Special Sponsored Section

34

4

Energy reform may be stealing the headlines in Mexico, but a rising regulatory authority, the beginnings of healthcare reform, and cost-competitive manufacturing are fueling future growth in the country’s pharma industry-for domestic and global players alike.